A comparison between upfront high-dose tirofiban versus provisional use in the real-world of non-selected STEMI patients undergoing primary PCI: Insights from the Zwolle acute myocardial infarction registry

BACKGROUND: Despite the proven benefit of glycoprotein IIb/IIIa blockers in patients with acute ST-segment elevation myocardial infarction (STEMI), there is still debate on the timing of administration of these drugs and whether all or only a selection of patients should be treated. We evaluated the...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Heestermans, A.A.C.M., Hermanides, R.S., Gosselink, A.T.M., de Boer, M.J., Hoorntje, J.C.A., Suryapranata, H., Ottervanger, J.P., Dambrink, J-H.E., Kolkman, E., ten Berg, J.M., Zijlstra, F., van ’t Hof, A.W.J.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Bohn Stafleu van Loghum 2010
Onderwerpen:
Original Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3018604/
https://ncbi.nlm.nih.gov/pubmed/21301621
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items